Bukwang Pharmaceutical Co., Ltd. (003000.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

18.2x

Market Cap

KRW 393.27B

MomentumView details →

1D Return

−0.62%

YTD Return

+7.79%

RSI (14)

45.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

18.2x

Market Cap

KRW 393.27B

RSI (14)

45.6

MomentumView details →

1D Return

−0.62%

YTD Return

+7.79%

ProfitabilityView details →

Gross Margin

45.89%

Net Margin

4.13%

EBITDA Margin

7.79%

ROE (TTM)

2.66%

ROA (TTM)

1.90%

Asset Turnover

0.46x

GrowthView details →

Revenue YoY

+20.05%

EPS YoY

−50.31%

FCF YoY

—

Revenue CAGR 3Y

+1.68%

EPS CAGR 3Y

+493.88%

EBITDA YoY

−0.12%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.24x

Current Ratio

2.33x

Quick Ratio

1.87x

Div Yield

3.09%

Div Rate

KRW 125.00

Div Growth 1Y

+25.00%

Financials snapshotView financials →

Revenue (TTM)

215.09B

Net Income (TTM)

8.89B

Op. CF (TTM)

3.39B

Latest newsMore news →

No recent news for 003000.KS.

Similar companies

Dong-A ST Co., Ltd.170900.KS Ildong Pharmaceutical Co., Ltd.249420.KS Kwang Dong Pharmaceutical Co., Ltd.009290.KS EuBiologics Co., Ltd.206650.KQ 恒瑞医药600276.SH Jiangsu Hengrui Pharmaceuticals Co.,Ltd01276.HK Find similar companies →

Latest newsMore news →

No recent news for 003000.KS.